, ritonavir) or discontinuation of the cytochrome P450 3A4 inducer including rifampin, carbamazepine, and phenytoin, may possibly bring about a rise in codeine plasma concentrations with subsequently larger metabolism by cytochrome P450 2D6, leading to higher morphine amounts, which could improve or extend adverse reactions and will result in probably https://akorn-promethazine-codein12221.blue-blogs.com/39377894/an-unbiased-view-of-akorn-promethazine-codeine